BioCryst Pharmaceuticals, Inc.
Edit Page
Report
Scan day: 05 February 2014 UTC
12
Virus safety - good
Description: Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX)
Ulodesine (BCX4208) Publications BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. Learn more about BioCryst’s broad spectrum antiviral
Size: 236 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | BioCryst: Home |
| Keywords: | biocryst,biocryst pharmaceuticals,bcrx,bcx4208,forodesine,peramivir,influenza,gout,stockpiling,seasonal flu,flu,pnp,purine nucleoside phosphorylase inhibitor,neuraminidase inhibitor,inflammatory diseases,cancer,infectious diseases,crystallography,structure-based drug design,BCX4161,BCX5191,Hepatitis C,hereditary angioedema,influenza antiviral,hospitalized influenza,Alabama biotech,North Carolina biotech,NC drug discovery,NC pharmaceuticals,Durham biotech,Birmingham biotech,uric acid reduction,enzyme inhibitors,ulodesine |
| Description: | BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. |
| IP-address: | 173.203.62.111 |
WHOIS Info
| NS | Name Server: NS53.WORLDNIC.COM Name Server: NS54.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 18-nov-1996 Expiration Date: 17-nov-2023 |